Bye-law 16, National Medical Commission (Fees of The manufacture of drugs) Bye-laws, 2024 [S57-C5A]

As at 7 September 2026. In force from 8 February 2024.

In National Medical Commission (Fees of The manufacture of drugs) Bye-laws, 2024 [R16-5YZ]. This text from 8 February 2024. No other text held.

Synthetic. This instrument, its title, its number and the words of this section are generated by the register.

Cite: Bye-law 16, National Medical Commission (Fees of The manufacture of drugs) Bye-laws, 2024 [S57-C5A]. Machine: S57-C5A.

Authorised agent.—Any manufacturer may authorise, in writing, an agent to make applications, furnish returns and receive notices on his behalf under these bye-laws, shall intimate to the State Medical Council in Form 21 the name and address of the agent within twenty-one days of the authorisation, and shall intimate the revocation of the authorisation within seven days of the revocation.

Defined terms in this text (0)

none

Made under this bye-law, or naming it (0)

none

Cited by (0)

none

Not held (0)

none

Duties published under this bye-law (0)

none